We have located links that may give you full text access.
Seventy-one-year-old woman followed with CMR during the course of systemic vasculitis.
Heart 2018 November 16
CLINICAL INTRODUCTION: A 71-year-old woman was diagnosed with systemic vasculitis in 2009 and received specific therapy (corticosteroids, cytostatic agents or rituximab in differing order). A transthoracic echocardiography (TTE) in 2013 for follow-up purposes of complications showed hyperechogenic endocardium of the whole left ventricular (LV) apex and cardiac MRI (CMR) was followed to further examine this finding. Using CMR, an apical LV thrombus was detected along with abnormal signal intensities within the endocardium (figure 1A). As a consequence, the existing medication was extended by phenprocoumon to treat the LV thrombus. For tracking the pathologic image features as well as for follow-up of the LV thrombus, serial CMRs were performed at our hospital from 2013 to 2018 (figure 1A). Because of the increasing hyperintense (white arrowheads) and hypointense (red arrowheads) signal spots in cine images of the apex (figure 1A), differently weighted sequences in short-axis view were acquired in the CMR of 2018 (figure 1B).
QUESTION: Which of the following is the most likely diagnosis in CMR?Microvascular ischaemiaCircular oedemaEndomyocardial fibrosisHaemorrhageApical lipoma.
QUESTION: Which of the following is the most likely diagnosis in CMR?Microvascular ischaemiaCircular oedemaEndomyocardial fibrosisHaemorrhageApical lipoma.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app